Evercore ISI restated their buy rating on shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in a research note issued to investors on Friday morning, AnalystRatings.Net reports. Evercore ISI currently has a $620.00 target price on the stock, up from their previous target price of $600.00.

Intuitive Surgical (NASDAQ:ISRG) traded down 2.06% during midday trading on Friday, hitting $534.02. 366,859 shares of the stock traded hands. The firm has a market cap of $19.92 billion and a PE ratio of 34.36. The stock has a 50-day moving average of $544.20 and a 200 day moving average of $514.00. Intuitive Surgical has a 52-week low of $447.00 and a 52-week high of $580.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 21st. The company reported $5.89 earnings per share for the quarter, topping the Zacks’ consensus estimate of $5.04 by $0.85. During the same quarter in the prior year, the company posted $4.92 earnings per share. The company had revenue of $676.50 million for the quarter, compared to analyst estimates of $655.32 million. The business’s revenue was up 11.9% on a year-over-year basis. Equities analysts forecast that Intuitive Surgical will post $20.67 EPS for the current year.

ISRG has been the subject of a number of other reports. Vetr upgraded shares of Intuitive Surgical from a hold rating to a buy rating and set a $521.38 price objective for the company in a research report on Monday, November 9th. Canaccord Genuity restated a buy rating and set a $625.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 22nd. Zacks Investment Research upgraded shares of Intuitive Surgical from a hold rating to a strong-buy rating and set a $571.00 price objective for the company in a research report on Friday, October 23rd. BTIG Research restated a buy rating and set a $575.00 price objective on shares of Intuitive Surgical in a research report on Thursday, October 22nd. Finally, Leerink Swann restated an outperform rating and set a $600.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, December 9th. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. The company has a consensus rating of Buy and an average target price of $622.88.

In other news, EVP Salvatore Brogna sold 2,734 shares of the stock in a transaction dated Monday, December 14th. The shares were sold at an average price of $530.00, for a total transaction of $1,449,020.00. Following the sale, the executive vice president now owns 692 shares of the company’s stock, valued at $366,760. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark J. Meltzer sold 1,625 shares of the stock in a transaction dated Friday, November 20th. The stock was sold at an average price of $515.00, for a total transaction of $836,875.00. Following the sale, the senior vice president now directly owns 996 shares in the company, valued at approximately $512,940. The disclosure for this sale can be found here.

Several hedge funds have modified their holdings of ISRG. Quantitative Systematic Strategies acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $301,000. Mizuho Asset Management Co. Ltd. boosted its stake in shares of Intuitive Surgical by 88.6% in the fourth quarter. Mizuho Asset Management Co. Ltd. now owns 762 shares of the company’s stock valued at $416,000 after buying an additional 358 shares in the last quarter. Dynamic Advisors Solutions boosted its stake in shares of Intuitive Surgical by 8.4% in the fourth quarter. Dynamic Advisors Solutions now owns 973 shares of the company’s stock valued at $531,000 after buying an additional 75 shares in the last quarter. Simplex Trading boosted its stake in shares of Intuitive Surgical by 50.5% in the fourth quarter. Simplex Trading now owns 143 shares of the company’s stock valued at $590,000 after buying an additional 48 shares in the last quarter. Finally, North American Management boosted its stake in shares of Intuitive Surgical by 2.8% in the fourth quarter. North American Management now owns 1,115 shares of the company’s stock valued at $609,000 after buying an additional 30 shares in the last quarter.

Intuitive Surgical, Inc. designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and vision system. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation and three-dimensional (NASDAQ:ISRG), high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures. Its da Vinci Surgery utilizes computational, robotic and imaging technologies. The Company has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company focuses on five surgical specialties: urologic surgery, gynecologic surgery, general surgery, cardiothoracic surgery, and head and neck surgery.

12 Month Chart for NASDAQ:ISRG

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.